Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report
2019 ◽
Vol 11
(2)
◽
pp. 456-460
◽
Rui Zhong
◽
Hui Li
◽
Yanling Liu
◽
Shuang Zhang
◽
Jingjing Liu
◽
...
Maria Joao Matos
◽
Claudia Costa
◽
Ana Paula Santos
◽
Manuel Teixeira
◽
Carlos Franco
◽
...
Vedrana Bulat
◽
Robert Likic
◽
Lada Bradic
◽
Reinhart Speeckaert
◽
Marija Delas Azdajic
2020 ◽
Vol 4
(4)
◽
pp. 125-128
Mona Arbab
◽
Gregory Bartlett
◽
Colleen DesRosiers
◽
Peter G Maxim
◽
Tim Lautenschlaeger
2019 ◽
Vol 26
◽
pp. 146-149
A. Lazopoulos
◽
D. Krimiotis
◽
N.C. Schizas
◽
T. Rallis
◽
A.S. Gogakos
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S946-S947
H. Ota
◽
E. Narisawa
◽
H. Chiba
◽
H. Nakayama
◽
Y. Tsukumo
◽
...
Keigo Koda
◽
Mikio Toyoshima
◽
Shusuke Yazawa
◽
Atsuki Fukada
◽
Haruhiko Sugimura
◽
...
Eleni Papakonstantinou
◽
Alexander Kapp
◽
Ulrike Raap
2013 ◽
Vol 81
(2)
◽
pp. 297-301
◽
Greta Alì
◽
Agnese Proietti
◽
Cristina Niccoli
◽
Serena Pelliccioni
◽
Nicla Borrelli
◽
...
2008 ◽
Vol 6
(1)
◽
pp. 120
◽
Stephanos Pericleous
◽
Samrat Mukherjee
◽
Robert R Hutchins
2017 ◽
Vol 12
(11)
◽
pp. S2247
C. Xu
◽
W. Wang
◽
W. Zhuang
◽
Y. Chen
◽
G. Chen
◽
...
Close
Export Citation Format
Close
Share Document
Close